Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: Management of paravalvular regurgitation after TAVR

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 2, 2013, Pages 300-311

  Martinez, Claudia A ^a   Singh, Vikas ^a   O'Neill, Brian P ^a   Alfonso, Carlos E ^a   Bilsker, Martin S ^a   Martinez Clark, Pedro ^a   Williams, Donald ^a   Cohen, Mauricio G ^a   Heldman, Alan W ^a   O'Neill, William W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

aortic stenosis; Edwards SAPIEN; paravalvular regurgitation; transcatheter aortic valve replacement

Indexed keywords

AGED; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; MORTALITY; PATIENT ASSESSMENT; PERCUTANEOUS AORTIC VALVE; SCORING SYSTEM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCATHETER CLOSURE;

AORTIC STENOSIS; EDWARDS SAPIEN; PARAVALVULAR REGURGITATION; TRANSCATHETER AORTIC VALVE REPLACEMENT;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880577896     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24807     Document Type: Article

References (27)

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008.
2. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
3. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN aortic bioprosthesis european outcome (SOURCE) registry: The European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011; 124: 425-433.
4. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
5. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308.
6. Mussardo M, Latib A, Chieffo A, et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC Cardiovasc Interv 2011; 4: 743-750.
7. Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: A report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009; 22: 975-1014; quiz 1082-1084.
8. Carabello BA, Paulus WJ,. Aortic stenosis. Lancet 2009; 373: 956-966.
9. Takagi K, Latib A, Al-Lamee R, et al. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after corevalve implantation and the impact of postdilatation. Catheter Cardiovasc Interv 2011; 78: 432-433.
10. Rajani R, Kakad M, Khawaja MZ, et al. Paravalvular regurgitation one year after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 75: 868-872.
11. Sherif MA, Abdel-Wahab M, Stocker B, et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol 2010; 56: 1623-1629.
12. Schultz CJ, Tzikas A, Moelker A, et al. Correlates on MSCT of paravalvular aortic regurgitation after transcatheter aortic valve implantation using the medtronic corevalve prosthesis. Catheter Cardiovasc Interv 2011; 78: 446-455.
13. Detaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: Implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2009; 2: 821-827.
14. Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation: Review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009; 2: 811-820.
15. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: Multicenter experience. Circulation 2007; 116: I240-I245.
16. Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 2009; 53: 1883-1891.
17. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies. The French experience. J Am Coll Cardiol 2006; 47: 1214-1223.
18. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: Impact on clinical and valve-related outcomes. Circulation 2009; 119: 3009-3016.
19. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
20. Kodali SK, Williams MR, Smith CR, et al. Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med 2012; 366: 1686-1695.
21. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the Valve Academic Research Consortium. Eur Heart J 2011; 32: 205-217.
22. Sinning JM, Hammerstingl C, Vasa-Nicotera M, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol 2012; 59: 1134-1141.
23. Vasa-Nicotera M, Sinning JM, Chin D, et al. Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012; 5: 858-865.
24. Willson AB, Webb JG, Labounty TM, et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: A multicenter retrospective analysis. J Am Coll Cardiol 2012; 59: 1287-1294.
25. Jilaihawi H, Kashif M, Fontana G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 2012; 59: 1275-1286.
26. Nietlispach F, Johnson M, Moss RR, et al. Transcatheter closure of paravalvular defects using a purpose-specific occluder. JACC Cardiovasc Interv 2010; 3: 759-765.
27. Martinez CA, O'Neill B, Singh V, O'Neill WW,. Transeptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement. Catheter Cardiovasc Interv 2012. doi: 10.1002/ccd.24678.